India Sepsis Diagnostics Market Size & Outlook, 2022-2030
India sepsis diagnostics market, 2018-2030 (US$M)
Related Markets
India sepsis diagnostics market highlights
- The India sepsis diagnostics market generated a revenue of USD 23.3 million in 2022 and is expected to reach USD 55.0 million by 2030.
- The India market is expected to grow at a CAGR of 11.3% from 2023 to 2030.
- In terms of segment, blood culture media was the largest revenue generating product in 2022.
- Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Sepsis diagnostics market data book summary
| Market revenue in 2022 | USD 23.3 million |
| Market revenue in 2030 | USD 55.0 million |
| Growth rate | 11.3% (CAGR from 2022 to 2030) |
| Largest segment | Blood culture media |
| Fastest growing segment | Assay Kits & Reagents |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
| Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Other key industry trends
- In terms of revenue, India accounted for 2.3% of the global sepsis diagnostics market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 77.2 million by 2030.
Blood culture media was the largest segment with a revenue share of 39.06% in 2022. Horizon Databook has segmented the India sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
The sepsis diagnostics market in India is expected to witness rapid growth driven by a combination of healthcare needs, technological innovations, and increased investment in medical infrastructure.
The high prevalence of diverse underlying health conditions, such as diabetes and cardiovascular diseases, significantly elevates the risk of sepsis, creating a strong demand for advanced diagnostic solutions.
According to WHO, around 77 million adults over 18 years old have type 2 diabetes in India. Similarly, according to a report published by the National Library of Medicine, in April 2024, the incidence of sepsis in India ranges between 540 and 640 cases per 100,000 people, with an estimated total burden of around 8.96 million cases.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Diagnostics Market Scope
Sepsis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
India sepsis diagnostics market size, by product, 2018-2030 (US$M)
India Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
